[Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature].
Lowenstein
W
W
Service de Médecine Interne, Hôpital Laennec, Paris.
Haas
C
C
Durand
H
H
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D002047:Buprenorphine / Q000627:therapeutic use; D003061:Codeine / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006679:HIV Seropositivity / Q000453:epidemiology; D015528:HIV Seroprevalence; D006556:Heroin Dependence / Q000150:complications / Q000534:rehabilitation*; D006801:Humans; D015994:Incidence; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D011446:Prospective Studies; D012307:Risk Factors; D012651:Self Medication; D011477:Sex Work; D012725:Sexual Behavior; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000517:prevention & control
D002047:Buprenorphine; D008691:Methadone; D003061:Codeine
Les traitements de substitution diminuent-ils l'incidence de l'infection par le virus de l'immuno-déficience humaine chez les héroïnomanes par voie veineuse? Recherche d'une bibliographie pertinente.